TAHMEENA HUSSAIN: Open Payments
NPI 1255586673 · PLAINSBORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 18 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $51 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $80 |
| ABBVIE INC. | 4 | $67 |
| PFIZER INC. | 3 | $47 |
| Novo Nordisk Inc | 2 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: UBRELVY, BREZTRI, LEQVIO, NURTEC ODT, Ozempic, PREVNAR 20, FARXIGA, ELIQUIS.
Industry payments across NJ — which companies pay providers there.
